EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity

E. Nizankowska-Mogilnicka; G. Bochenek; L. Mastalerz; M. Świerczyńska; C. Picado; G. Scadding; M. L. Kowalski; M. Setkowicz; J. Ring; K. Brockow; C. Bachert; S. Wöhrl; B. Dahlén; A. Szczeklik

doi:10.1111/j.1398-9995.2007.01409.x

EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity

E. Nizankowska-Mogilnicka
, G. Bochenek
, L. Mastalerz
, M. Świerczyńska
, C. Picado
, G. Scadding
, M. L. Kowalski
, M. Setkowicz
, J. Ring
, K. Brockow
, C. Bachert
, S. Wöhrl
, B. Dahlén
, A. Szczeklik

Jagiellonian University Medical College
Universitat de Barcelona
Royal National Throat, Nose and Ear Hospital
Medical University of Lodz
Ghent University
Medical University of Vienna
Karolinska Institutet

Research output: Contribution to journal › Review article › peer-review

408 Scopus citations

Abstract

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

Original language	English
Pages (from-to)	1111-1118
Number of pages	8
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	62
Issue number	10
DOIs	https://doi.org/10.1111/j.1398-9995.2007.01409.x
State	Published - Oct 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Aspirin
Aspirin challenge
Aspirin-induced asthma/rhinitis
Aspirin-induced urticaria
Hypersensitivity

Access to Document

10.1111/j.1398-9995.2007.01409.x

Cite this

Nizankowska-Mogilnicka, E., Bochenek, G., Mastalerz, L., Świerczyńska, M., Picado, C., Scadding, G., Kowalski, M. L., Setkowicz, M., Ring, J., Brockow, K., Bachert, C., Wöhrl, S., Dahlén, B., & Szczeklik, A. (2007). EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy: European Journal of Allergy and Clinical Immunology, 62(10), 1111-1118. https://doi.org/10.1111/j.1398-9995.2007.01409.x

@article{e9231bdf51164b17babd6d86b1ee0620,

title = "EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity",

abstract = "Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.",

keywords = "Aspirin, Aspirin challenge, Aspirin-induced asthma/rhinitis, Aspirin-induced urticaria, Hypersensitivity",

author = "E. Nizankowska-Mogilnicka and G. Bochenek and L. Mastalerz and M. {\'S}wierczy{\'n}ska and C. Picado and G. Scadding and Kowalski, \{M. L.\} and M. Setkowicz and J. Ring and K. Brockow and C. Bachert and S. W{\"o}hrl and B. Dahl{\'e}n and A. Szczeklik",

year = "2007",

month = oct,

doi = "10.1111/j.1398-9995.2007.01409.x",

language = "English",

volume = "62",

pages = "1111--1118",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "10",

}

Nizankowska-Mogilnicka, E, Bochenek, G, Mastalerz, L, Świerczyńska, M, Picado, C, Scadding, G, Kowalski, ML, Setkowicz, M, Ring, J , Brockow, K, Bachert, C, Wöhrl, S, Dahlén, B & Szczeklik, A 2007, 'EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity', Allergy: European Journal of Allergy and Clinical Immunology, vol. 62, no. 10, pp. 1111-1118. https://doi.org/10.1111/j.1398-9995.2007.01409.x

TY - JOUR

T1 - EAACI/GA2LEN guideline

T2 - Aspirin provocation tests for diagnosis of aspirin hypersensitivity

AU - Nizankowska-Mogilnicka, E.

AU - Bochenek, G.

AU - Mastalerz, L.

AU - Świerczyńska, M.

AU - Picado, C.

AU - Scadding, G.

AU - Kowalski, M. L.

AU - Setkowicz, M.

AU - Ring, J.

AU - Brockow, K.

AU - Bachert, C.

AU - Wöhrl, S.

AU - Dahlén, B.

AU - Szczeklik, A.

PY - 2007/10

Y1 - 2007/10

N2 - Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

AB - Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

KW - Aspirin

KW - Aspirin challenge

KW - Aspirin-induced asthma/rhinitis

KW - Aspirin-induced urticaria

KW - Hypersensitivity

UR - https://www.scopus.com/pages/publications/34548473304

U2 - 10.1111/j.1398-9995.2007.01409.x

DO - 10.1111/j.1398-9995.2007.01409.x

M3 - Review article

C2 - 17521312

AN - SCOPUS:34548473304

SN - 0105-4538

VL - 62

SP - 1111

EP - 1118

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 10

ER -

EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this